Creating disease-modifying gene therapies for CNS disorders with our cell-selective targeting and regulation platform. Guidelines: https://nitter.gq/t.co/Flbfrl3SAg
South San Francisco, CA
Joined October 2017
- Tweets352
- Following464
- Followers322
- Likes24
We're proud to support the FAST Global Science Summit and collaborate with the Angelman syndrome community to help advance research and innovation. Join us Saturday to learn more about our investigational gene therapy approach designed to restore UBE3A expression.
#FASTSummit
In Hamburg for #ESGCT2026, contributing to the scientific exchange advancing gene therapy in Europe.
Don’t miss our CMO, Salvador Rico, sharing seizure and neurodevelopmental data from the Phase 1/2 clinical trials of ETX101, our investigational #genetherapy for Dravet syndrome.
Off to Montreal for @ChildNeuroSoc Annual Meeting. Catch Joseph Sullivan, VP of Clinical Development, sharing Phase 1/2 data on ETX101 — our investigational #genetherapy for Dravet syndrome.
#CNSAM
Encoded was honored to sponsor and attend the Research Roundtable for Rare Genetic Neurodevelopmental Disorders (RGND). We’re proud to support cross-sector collaboration to address R&D roadblocks and drive actionable change for RGND patients and families.
Stephanie Tagliatela, CSO, will present Restoring SCN1A Mediated Neuronal Excitability Through Cell Selective Gene Regulation in Clinical Dravet Syndrome at the Ion Channel Targeted Drug Discovery Summit in Boston: bit.ly/3UVOpHu
#ionchannels
We’re hiring across #SupplyChain, #InternalManufacturing, and #QualityAssurance to support our expanding development and manufacturing operations in NC.
Learn more: Careers – Encoded Therapeutics ow.ly/McEZ50ZPSws
#GeneTherapy #BiotechCareers #BiotechJobs
#EEC2026: Prof. Ingrid Scheffer, University of Melbourne, presented new POLARIS data, Emma James, Encoded, contributed to a mini-forum on disease-modification trials, and the team met with leaders across the epilepsy community. Here’s the data release: encoded.com/encoded-therapeu…
We closed a $275 million financing co-led by GV and another healthcare fund, with support from new and existing investors. Funding will advance ETX101 for Dravet syndrome and support broader pipeline advancement. Learn more encoded.com/encoded-therapeu…
Professor Ingrid Scheffer of the University of Melbourne will present new ETX101 data during a platform presentation at #EEC2026 on September 7.
Learn more: ow.ly/oGxF50ZIn6G
At the 2026 BRAIN Initiative Conference, Stephanie Tagliatela, CSO, joins the Aug 13 session on Precision Molecular Circuit Therapies. Encoded is proud to contribute.
#BRAINconference
